Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S416000
Reexamination Certificate
active
06875791
ABSTRACT:
The invention relates to polycyclic aryl and heteroaryl substituted 4-pyrone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
REFERENCES:
patent: 4489096 (1984-12-01), Terao et al.
patent: 4851413 (1989-07-01), Terao et al.
patent: 4992469 (1991-02-01), Ozawa et al.
patent: 5304658 (1994-04-01), Terao et al.
patent: 5441960 (1995-08-01), Bernstein et al.
patent: 5656645 (1997-08-01), Tamura et al.
patent: 5658930 (1997-08-01), Tamura et al.
patent: 5668289 (1997-09-01), Sanderson et al.
patent: 5741819 (1998-04-01), Illig et al.
patent: 5792779 (1998-08-01), Sanderson et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5866573 (1999-02-01), Sanderson et al.
patent: 5869487 (1999-02-01), Coburn et al.
patent: 5872138 (1999-02-01), Naylor-Olsen et al.
patent: 6011158 (2000-01-01), Tamura et al.
patent: 6037356 (2000-03-01), Lu et al.
patent: 6180627 (2001-01-01), Blagg et al.
patent: 198 51 421 (2000-05-01), None
patent: 0 354 495 (1990-02-01), None
patent: 0 528 633 (1993-02-01), None
patent: 0 826 671 (1998-03-01), None
patent: 0 936 216 (1999-08-01), None
patent: 0 940 400 (1999-09-01), None
patent: 0 997 474 (2000-05-01), None
patent: WO 9321214 (1993-10-01), None
patent: WO 9618644 (1996-06-01), None
patent: WO 9633974 (1996-10-01), None
patent: WO 9639380 (1996-12-01), None
patent: WO 9640100 (1996-12-01), None
patent: WO 9701338 (1997-01-01), None
patent: WO 9730708 (1997-08-01), None
patent: WO 9740024 (1997-10-01), None
patent: WO 9746207 (1997-12-01), None
patent: WO 9808840 (1998-03-01), None
patent: WO 9809949 (1998-03-01), None
patent: WO 9809987 (1998-03-01), None
patent: WO 9810763 (1998-03-01), None
patent: WO 9816525 (1998-04-01), None
patent: WO 9816547 (1998-04-01), None
patent: WO 9817274 (1998-04-01), None
patent: WO 9831670 (1998-07-01), None
patent: WO 9842342 (1998-10-01), None
patent: WO 9847876 (1998-10-01), None
patent: WO 9850420 (1998-11-01), None
patent: WO 9900121 (1999-01-01), None
patent: WO 9900126 (1999-01-01), None
patent: WO 9900128 (1999-01-01), None
patent: WO 9911267 (1999-03-01), None
patent: WO 9926920 (1999-06-01), None
patent: WO 9926926 (1999-06-01), None
patent: WO 9936426 (1999-07-01), None
patent: WO 9943660 (1999-09-01), None
patent: WO 9948892 (1999-09-01), None
patent: WO 9959591 (1999-11-01), None
patent: WO 9961442 (1999-12-01), None
patent: WO 9962538 (1999-12-01), None
patent: WO 9964446 (1999-12-01), None
patent: WO 0018762 (2000-04-01), None
patent: WO 0026210 (2000-05-01), None
patent: WO 0026211 (2000-05-01), None
patent: WO 0032574 (2000-06-01), None
patent: WO 0039102 (2000-07-01), None
patent: WO 0069826 (2000-11-01), None
patent: WO 0069832 (2000-11-01), None
patent: WO 0069833 (2000-11-01), None
patent: WO 0177097 (2001-10-01), None
Coburn, C.A., “Small-molecule direct thrombine inhibitors 1997-2000.” Expert Opinions on Therapeutic Patents, 2001, 721-738, vol. 11, No. 5.
XP-002182132—Darvas, et al., “Investigation of the Common Mechanism of Action of Antibacterial Compounds Containing .gamma.-pyridone-.beta.-carboxylic acid Structure by Principal Component.” Arzneim.-Forshc., 1979, pp. 1334-1339, vol. 29, 9.
Handin, R., “Bleeding and Thrombosis.” Harrison's Principles of Internal Medicine, 12th Edition, 1991, pp. 348-353, McGraw-Hill, Inc., New York.
Majerus, et al. “Anticoagulant, Thrombolytic, and Antiplatlet Drugs.” Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, 1996, pp. 1341-1359, McGraw-Hill, New York.
XP-002187583—MOERNER, Hoppe-Seyler's Z. Physiol. Chem., 69, 1910; 357.
Patel et al., “Directed Aminomethylation of 3-Hydroxy-3(1H)-pyridinones and 3-hydroxy-4(1H)-pyridinones: Synthesis of iso-Deferiprone,” Tetrahedron, 1996, pp. 1835-1840, vol. 52, No. 5.
Rauch et al., “Thrombus Formation on Atheroscleratic Plaques: Pathogenesis and Clinical Consequences.” Animals of Internal Medicine, 2001, pp. 224-233, vol. 134, No. 3.
Sanderson et al., “L-373,890, An Achiral, Noncovalent, Subnamomolar Thrombin Inhibitor.” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 12, pp. 1497-1500, 1997.
XP-002182410—Trecourt et al., “First Synthesis of (+-)-harzianopyridone by Metalation of Polysubstituted O-pyridylcarbamates.” J. Heterocycl. Chem., 1995, pp. 1117-1114, vol. 32, No. 4.
Tulinsky et al., “Novel Asymmetric Synthesis of Atropisomeric 6-Aryl Pyrazinones via an Unusual Chirality Transfer Process.” J. Org. Chem., 1999, pp. 93-100, vol. 64, No. 1.
Van Aken, et al., “Anticoagulation: The Present and Future.” Clin. Appl. Thromiosis/Hemostasis, 2001, vol. 7, No. 3.
Koeller Kevin J.
Ma Chun C.
Neumann William L.
Rahman Hayat K.
South Michael S.
Pharmacia Corporation
Solola Taofiq
LandOfFree
Polycyclic aryl and heteroaryl substituted 4-pyrones useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic aryl and heteroaryl substituted 4-pyrones useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic aryl and heteroaryl substituted 4-pyrones useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378905